Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Autoimmune Disorders

  Free Subscription


3 BMC Neurol
1 Curr Opin Immunol
1 Intern Med
6 J Immunol
8 J Neuroimmunol
2 J Neurol
1 Lancet Oncol
2 Mult Scler
1 N Engl J Med
1 Nat Rev Neurol
8 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    BMC Neurol

  1. HOFFMANN FA, Trenova A, Llaneza MA, Fischer J, et al
    Patient satisfaction with ExtaviPro 30G, a new auto-injector for administering interferon beta-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study.
    BMC Neurol. 2017;17:156.
    PubMed     Text format     Abstract available

  2. RAGONESE P, Aridon P, Vazzoler G, Mazzola MA, et al
    Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study.
    BMC Neurol. 2017;17:155.
    PubMed     Text format     Abstract available

  3. ACHIRON A, Aref H, Inshasi J, Harb M, et al
    Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East.
    BMC Neurol. 2017;17:150.
    PubMed     Text format     Abstract available

    Curr Opin Immunol

  4. ROMI F, Hong Y, Gilhus NE
    Pathophysiology and immunological profile of myasthenia gravis and its subgroups.
    Curr Opin Immunol. 2017;49:9-13.
    PubMed     Text format     Abstract available

    Intern Med

  5. YAMADA M, Shibata H, Masugi Y, Ishi T, et al
    Histological Changes in Autoimmune Hepatitis with Graves' Disease: A Child Case Report.
    Intern Med. 2017 Aug 1. doi: 10.2169/internalmedicine.8417.
    PubMed     Text format     Abstract available

    J Immunol

  6. NEUMANN K, Karimi K, Meiners J, Voetlause R, et al
    A Proinflammatory Role of Type 2 Innate Lymphoid Cells in Murine Immune-Mediated Hepatitis.
    J Immunol. 2016 Nov 21. pii: 1600418.
    PubMed     Text format     Abstract available

  7. BUIE JJ, Renaud LL, Muise-Helmericks R, Oates JC, et al
    IFN-alpha Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus.
    J Immunol. 2017 Aug 4. pii: ji1600108. doi: 10.4049/jimmunol.1600108.
    PubMed     Text format     Abstract available

  8. VISPERAS A, Vignali DA
    Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?
    J Immunol. 2016;197:3762-3770.
    PubMed     Text format     Abstract available

  9. BALLY AP, Tang Y, Lee JT, Barwick BG, et al
    Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory.
    J Immunol. 2017;198:205-217.
    PubMed     Text format     Abstract available

  10. TAN C, Wandu WS, Lee RS, Hinshaw SH, et al
    Shedding New Light on the Process of "Licensing" for Pathogenicity by Th Lymphocytes.
    J Immunol. 2017;198:681-690.
    PubMed     Text format     Abstract available

  11. PAUN A, Yau C, Danska JS
    The Influence of the Microbiome on Type 1 Diabetes.
    J Immunol. 2017;198:590-595.
    PubMed     Text format     Abstract available

    J Neuroimmunol

  12. HAITAO R, Huiqin L, Tao Q, Xunzhe Y, et al
    Autoimmune encephalitis associated with vitiligo?
    J Neuroimmunol. 2017;310:14-16.
    PubMed     Text format     Abstract available

  13. DELGADO-GARCIA G, Corona-Vazquez T
    IgG4-related disease and IgG4-mediated neurological autoimmune disorders: One and the same?
    J Neuroimmunol. 2017;310:129-130.
    PubMed     Text format    

  14. JAHAN I, Ahammad RU, Farzana KS, Khalid MM, et al
    Tumor necrosis factor-alpha -863C/A polymorphism is associated with Guillain-Barre syndrome in Bangladesh.
    J Neuroimmunol. 2017;310:46-50.
    PubMed     Text format     Abstract available

  15. CHANGYALEKET B, Deliu Z, Chignalia AZ, Feinstein DL, et al
    Heparanase: Potential roles in multiple sclerosis.
    J Neuroimmunol. 2017;310:72-81.
    PubMed     Text format     Abstract available

  16. VILLANI S, Zanotta N, Ambrogi F, Comar M, et al
    Multiplex array analysis of circulating cytokines and chemokines in natalizumab-treated patients with multiple sclerosis.
    J Neuroimmunol. 2017;310:91-96.
    PubMed     Text format     Abstract available

  17. JING S, Song Y, Song J, Pang S, et al
    Responsiveness to low-dose rituximab in refractory generalized myasthenia gravis.
    J Neuroimmunol. 2017 May 30. pii: S0165-5728(17)30074.
    PubMed     Text format     Abstract available

  18. NIELSEN BR, Ratzer R, Bornsen L, von Essen MR, et al
    Characterization of naive, memory and effector T cells in progressive multiple sclerosis.
    J Neuroimmunol. 2017;310:17-25.
    PubMed     Text format     Abstract available

  19. PENN M, Mausner-Fainberg K, Golan M, Karni A, et al
    High serum levels of BMP-2 correlate with BMP-4 and BMP-5 levels and induce reduced neuronal phenotype in patients with relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2017;310:120-128.
    PubMed     Text format     Abstract available

    J Neurol

  20. HRASTELJ J, Robertson N
    Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies.
    J Neurol. 2017 Aug 7. doi: 10.1007/s00415-017-8584.
    PubMed     Text format    

  21. FINKE C, Bartels F, Lutt A, Pruss H, et al
    High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.
    J Neurol. 2017 Aug 7. doi: 10.1007/s00415-017-8582.
    PubMed     Text format     Abstract available

    Lancet Oncol

  22. HEERY CR, O'Sullivan-Coyne G, Madan RA, Cordes L, et al
    Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial.
    Lancet Oncol. 2017;18:587-598.
    PubMed     Text format     Abstract available

    Mult Scler

  23. LAROCCA NG, Hudson LD, Rudick R, Amtmann D, et al
    The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.
    Mult Scler. 2017 Aug 1:1352458517723718. doi: 10.1177/1352458517723718.
    PubMed     Text format     Abstract available

  24. VAVASOUR IM, Huijskens SC, Li DK, Traboulsee AL, et al
    Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter.
    Mult Scler. 2017 Aug 1:1352458517723717. doi: 10.1177/1352458517723717.
    PubMed     Text format     Abstract available

    N Engl J Med

  25. DIVAKARAN S, Dellaripa P, Kobzik L, Levy B, et al
    All That Wheezes....
    N Engl J Med. 2017;377:477-484.
    PubMed     Text format    

    Nat Rev Neurol

  26. SOLOMON AJ, Corboy JR
    The tension between early diagnosis and misdiagnosis of multiple sclerosis.
    Nat Rev Neurol. 2017 Aug 11. doi: 10.1038/nrneurol.2017.
    PubMed     Text format    

    PLoS One

  27. OBERT D, Helms G, Sattler MB, Jung K, et al
    Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.
    PLoS One. 2016;11:e0162583.
    PubMed     Text format     Abstract available

  28. URRUTIA I, Martinez R, Lopez-Euba T, Velayos T, et al
    Lower Frequency of HLA-DRB1 Type 1 Diabetes Risk Alleles in Pediatric Patients with MODY.
    PLoS One. 2017;12:e0169389.
    PubMed     Text format     Abstract available

  29. BYTOFT B, Knorr S, Vlachova Z, Jensen RB, et al
    Assessment of Attention Deficits in Adolescent Offspring Exposed to Maternal Type 1 Diabetes.
    PLoS One. 2017;12:e0169308.
    PubMed     Text format     Abstract available

  30. YEUNG KS, Chung BH, Choufani S, Mok MY, et al
    Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway.
    PLoS One. 2017;12:e0169553.
    PubMed     Text format     Abstract available

  31. BONFIGLIO T, Olivero G, Merega E, Di Prisco S, et al
    Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
    PLoS One. 2017;12:e0170825.
    PubMed     Text format     Abstract available

  32. YUAN C, Chu CC, Yan XJ, Bagnara D, et al
    The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    PLoS One. 2017;12:e0167602.
    PubMed     Text format     Abstract available

  33. ATKILT HS, Turago MG, Tegegne BS
    Clinical Characteristics of Diabetic Ketoacidosis in Children with Newly Diagnosed Type 1 Diabetes in Addis Ababa, Ethiopia: A Cross-Sectional Study.
    PLoS One. 2017;12:e0169666.
    PubMed     Text format     Abstract available

  34. CLAUSEN TD, Bergholt T, Bouaziz O, Arpi M, et al
    Broad-Spectrum Antibiotic Treatment and Subsequent Childhood Type 1 Diabetes: A Nationwide Danish Cohort Study.
    PLoS One. 2016;11:e0161654.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  35. MAGILNICK N, Reyes EY, Wang WL, Vonderfecht SL, et al
    miR-146a-Traf6 regulatory axis controls autoimmunity and myelopoiesis, but is dispensable for hematopoietic stem cell homeostasis and tumor suppression.
    Proc Natl Acad Sci U S A. 2017 Aug 7. pii: 201706833.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.